aluates Reports

$ 0.0

Automative

Global SARS-Cov-2 Vaccine (Vero Cell) Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-29O9882

Global SARS Cov 2 Vaccine Vero Cell Market Insights Forecast to 2028

BUY CHAPTERS

Global SARS-Cov-2 Vaccine (Vero Cell) Market Research Report 2025

Code: QYRE-Auto-29O9882

Report

July 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sinopharm

SINOVAC BIOTECH

WIBP

BIBP

IMBCAMS,China

Pfizer Inc

SARS-Cov-2 Vaccine (Vero Cell) Market Size

The global market for SARS-Cov-2 Vaccine (Vero Cell) was valued at US$ 15970 million in the year 2024 and is projected to reach a revised size of US$ 33460 million by 2031, growing at a CAGR of 11.3% during the forecast period.

SARS-Cov-2 Vaccine (Vero Cell) Market

SARS-Cov-2 Vaccine (Vero Cell) is an immune product made to prevent and control the occurrence and prevalence of infectious diseases caused by the new coronavirus

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for SARS-Cov-2 Vaccine (Vero Cell), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SARS-Cov-2 Vaccine (Vero Cell).

The SARS-Cov-2 Vaccine (Vero Cell) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global SARS-Cov-2 Vaccine (Vero Cell) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the SARS-Cov-2 Vaccine (Vero Cell) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of SARS-Cov-2 Vaccine (Vero Cell) Market Report

Report Metric	Details
Report Name	SARS-Cov-2 Vaccine (Vero Cell) Market
Accounted market size in year	US$ 15970 million
Forecasted market size in 2031	US$ 33460 million
CAGR	11.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Whole Virus Inactivated Vaccine Split Vaccine Subunit Vaccine Others
Segment by Application	Special Population General Population
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sinopharm, Sinovac Biotech, BIBP, IMBCAMS,China, WIBP, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of SARS-Cov-2 Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of SARS-Cov-2 Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is SARS-Cov-2 Vaccine (Vero Cell) Market growing?

Ans: The SARS-Cov-2 Vaccine (Vero Cell) Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the SARS-Cov-2 Vaccine (Vero Cell) Market size in 2031?

Ans: The SARS-Cov-2 Vaccine (Vero Cell) Market size in 2031 will be US$ 33460 million.

Who are the main players in the SARS-Cov-2 Vaccine (Vero Cell) Market report?

Ans: The main players in the SARS-Cov-2 Vaccine (Vero Cell) Market are Sinopharm, Sinovac Biotech, BIBP, IMBCAMS,China, WIBP, Pfizer

What are the Application segmentation covered in the SARS-Cov-2 Vaccine (Vero Cell) Market report?

Ans: The Applications covered in the SARS-Cov-2 Vaccine (Vero Cell) Market report are Special Population, General Population

What are the Type segmentation covered in the SARS-Cov-2 Vaccine (Vero Cell) Market report?

Ans: The Types covered in the SARS-Cov-2 Vaccine (Vero Cell) Market report are Whole Virus Inactivated Vaccine, Split Vaccine, Subunit Vaccine, Others

Recommended Reports

COVID-19 Vaccine

Other Infectious Vaccines

Vaccine Logistics & Packaging

1 SARS-Cov-2 Vaccine (Vero Cell) Market Overview

1.1 Product Definition

1.2 SARS-Cov-2 Vaccine (Vero Cell) by Type

1.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Whole Virus Inactivated Vaccine

1.2.3 Split Vaccine

1.2.4 Subunit Vaccine

1.2.5 Others

1.3 SARS-Cov-2 Vaccine (Vero Cell) by Application

1.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Value by Application (2024 VS 2031)

1.3.2 Special Population

1.3.3 General Population

1.4 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Estimates and Forecasts

1.4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue 2020-2031

1.4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales 2020-2031

1.4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 SARS-Cov-2 Vaccine (Vero Cell) Market Competition by Manufacturers

2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2020-2025)

2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of SARS-Cov-2 Vaccine (Vero Cell), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Product Type & Application

2.7 Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Date of Enter into This Industry

2.8 Global SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Situation and Trends

2.8.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players Market Share by Revenue

2.8.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Scenario by Region

3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2020-2031

3.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2020-2025

3.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region: 2026-2031

3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2020-2031

3.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2020-2025

3.3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2026-2031

3.4 North America SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country

3.4.1 North America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2031)

3.4.3 North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country

3.5.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2031)

3.5.3 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Region

3.6.1 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2020-2031)

3.6.3 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country

3.7.1 Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2031)

3.7.3 Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country

3.8.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2031)

3.8.3 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2020-2031)

4.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2020-2025)

4.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Type (2026-2031)

4.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2020-2031)

4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2020-2031)

4.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2020-2025)

4.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Type (2026-2031)

4.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2020-2031)

4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2020-2031)

5 Segment by Application

5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2020-2031)

5.1.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2020-2025)

5.1.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Application (2026-2031)

5.1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2020-2031)

5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2020-2031)

5.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2020-2025)

5.2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Application (2026-2031)

5.2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2020-2031)

5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sinopharm

6.1.1 Sinopharm Company Information

6.1.2 Sinopharm Description and Business Overview

6.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio

6.1.5 Sinopharm Recent Developments/Updates

6.2 Sinovac Biotech

6.2.1 Sinovac Biotech Company Information

6.2.2 Sinovac Biotech Description and Business Overview

6.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio

6.2.5 Sinovac Biotech Recent Developments/Updates

6.3 BIBP

6.3.1 BIBP Company Information

6.3.2 BIBP Description and Business Overview

6.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio

6.3.5 BIBP Recent Developments/Updates

6.4 IMBCAMS,China

6.4.1 IMBCAMS,China Company Information

6.4.2 IMBCAMS,China Description and Business Overview

6.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio

6.4.5 IMBCAMS,China Recent Developments/Updates

6.5 WIBP

6.5.1 WIBP Company Information

6.5.2 WIBP Description and Business Overview

6.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio

6.5.5 WIBP Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Company Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Chain Analysis

7.2 SARS-Cov-2 Vaccine (Vero Cell) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 SARS-Cov-2 Vaccine (Vero Cell) Production Mode & Process Analysis

7.4 SARS-Cov-2 Vaccine (Vero Cell) Sales and Marketing

7.4.1 SARS-Cov-2 Vaccine (Vero Cell) Sales Channels

7.4.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors

7.5 SARS-Cov-2 Vaccine (Vero Cell) Customer Analysis

8 SARS-Cov-2 Vaccine (Vero Cell) Market Dynamics

8.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Trends

8.2 SARS-Cov-2 Vaccine (Vero Cell) Market Drivers

8.3 SARS-Cov-2 Vaccine (Vero Cell) Market Challenges

8.4 SARS-Cov-2 Vaccine (Vero Cell) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sinopharm

SINOVAC BIOTECH

WIBP

BIBP

IMBCAMS,China

Pfizer Inc

List of Tables

Table 1. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Situation by Manufacturers in 2024

Table 4. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market SARS-Cov-2 Vaccine (Vero Cell) Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of SARS-Cov-2 Vaccine (Vero Cell), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Product Type & Application

Table 12. Global Key Manufacturers of SARS-Cov-2 Vaccine (Vero Cell), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global SARS-Cov-2 Vaccine (Vero Cell) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-Cov-2 Vaccine (Vero Cell) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2020-2025) & (K Units)

Table 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2020-2025)

Table 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2026-2031) & (K Units)

Table 20. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2026-2031)

Table 21. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2020-2025)

Table 23. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2026-2031)

Table 25. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)

Table 27. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)

Table 28. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)

Table 32. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)

Table 33. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Type (2020-2025)

Table 51. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Type (2026-2031)

Table 52. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2020-2025)

Table 53. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2026-2031)

Table 54. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2020-2025)

Table 57. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2026-2031)

Table 58. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2020-2025)

Table 59. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2026-2031)

Table 60. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Application (2020-2025)

Table 61. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Application (2026-2031)

Table 62. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2020-2025)

Table 63. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2026-2031)

Table 64. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2020-2025)

Table 67. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2026-2031)

Table 68. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2020-2025)

Table 69. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2026-2031)

Table 70. Sinopharm Company Information

Table 71. Sinopharm Description and Business Overview

Table 72. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product

Table 74. Sinopharm Recent Developments/Updates

Table 75. Sinovac Biotech Company Information

Table 76. Sinovac Biotech Description and Business Overview

Table 77. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product

Table 79. Sinovac Biotech Recent Developments/Updates

Table 80. BIBP Company Information

Table 81. BIBP Description and Business Overview

Table 82. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product

Table 84. BIBP Recent Developments/Updates

Table 85. IMBCAMS,China Company Information

Table 86. IMBCAMS,China Description and Business Overview

Table 87. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product

Table 89. IMBCAMS,China Recent Developments/Updates

Table 90. WIBP Company Information

Table 91. WIBP Description and Business Overview

Table 92. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product

Table 94. WIBP Recent Developments/Updates

Table 95. Pfizer Company Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Pfizer SARS-Cov-2 Vaccine (Vero Cell) Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. SARS-Cov-2 Vaccine (Vero Cell) Distributors List

Table 103. SARS-Cov-2 Vaccine (Vero Cell) Customers List

Table 104. SARS-Cov-2 Vaccine (Vero Cell) Market Trends

Table 105. SARS-Cov-2 Vaccine (Vero Cell) Market Drivers

Table 106. SARS-Cov-2 Vaccine (Vero Cell) Market Challenges

Table 107. SARS-Cov-2 Vaccine (Vero Cell) Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of SARS-Cov-2 Vaccine (Vero Cell)

Figure 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Type: 2024 & 2031

Figure 4. Whole Virus Inactivated Vaccine Product Picture

Figure 5. Split Vaccine Product Picture

Figure 6. Subunit Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global SARS-Cov-2 Vaccine (Vero Cell) Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application: 2024 & 2031

Figure 10. Special Population

Figure 11. General Population

Figure 12. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size (2020-2031) & (US$ Million)

Figure 14. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (2020-2031) & (K Units)

Figure 15. Global SARS-Cov-2 Vaccine (Vero Cell) Average Price (US$/Unit) & (2020-2031)

Figure 16. SARS-Cov-2 Vaccine (Vero Cell) Report Years Considered

Figure 17. SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Manufacturers in 2024

Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players: Market Share by Revenue in SARS-Cov-2 Vaccine (Vero Cell) in 2024

Figure 20. SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)

Figure 23. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)

Figure 24. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)

Figure 27. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)

Figure 28. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2020-2031)

Figure 35. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)

Figure 45. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)

Figure 46. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)

Figure 51. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2020-2031)

Figure 55. Global Revenue Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2020-2031)

Figure 56. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Application (2020-2031)

Figure 58. Global Revenue Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Application (2020-2031)

Figure 59. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2020-2031)

Figure 60. SARS-Cov-2 Vaccine (Vero Cell) Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Covid 19 Vaccine Market Research Report 2024

Global Vero Cell Rabies Vaccines for Human Market Research Report 2025

Global SARS CoV 2 Antigen Test Kit Market Research Report 2025

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumour cell Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 RNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Coronavirus COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Vaccines Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Vaccines Market Insights Forecast to 2030

Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions